LongevityNext

Intervention

Elamipretide

Source-reviewedGoverned LongevityNext intelligence profile
Evidence reviewed through2026-08-07

Executive intelligence snapshot

Current reviewed view

The primary walking endpoint was negative, while several secondary patient-reported outcomes favored elamipretide.

This profile includes 3 reviewed relationship(s) and 4 reviewed source(s).

This view is bounded by reviewed evidence and does not provide a recommendation or a claim beyond the stated review date.

Evidence state

Source-reviewed

Evidence reviewed through2026-08-07

Evidence state

What the evidence supports

The primary walking endpoint was negative, while several secondary patient-reported outcomes favored elamipretide.

Evidence boundary

Key limitations

  • Patient-reported fatigue measures showed nominal improvements, so the trial did not establish absence of all clinical activity.

    Does not establish efficacy, mechanism falsification, approval, utility, rejuvenation, or investment attractiveness.

Not established

Key unknowns

  • Dose, route, population, and outcomes not recorded in this reviewed profile remain unknown.

    The reviewed evidence does not resolve this dimension beyond the recorded boundary.

Next evidence milestone

What would change this view?

No specific evidence milestone is recorded yet.

Evidence reviewed through 2026-08-07.

Intelligence connections

Reviewed source layer

Evidence & sources

These cards show only metadata present in the reviewed source registry.

Technical provenance
Object key
intervention:LNPG-ENT-10bc4992-6ea1-4246-b519-63c99eafef61
Source release
LNPG-REL-20260807-027
Mapping version
0.2.0
Presentation release
LNPG-REL-20260808-037
Projection hash
996b48db376682406f6de531df84bcbf2dd08e0c8d5b22e617edbbe61aafc778

Source identifiers

  • LNPG-SRC-2fe4441a-86e0-4318-a426-472580a838d6
  • LNPG-SRC-cd07dfa8-3600-4672-952c-c98e29fae4e1
  • LNPG-SRC-d42b1dd3-76e2-4a7a-bb3b-2c3773684e86
  • LNPG-SRC-ed8885e5-13d5-4443-b582-567c4a54e52e

Directed relationship identities

  • edge:00173 — intervention_exactly_links_company
  • edge:00174 — intervention_tested_in_trial
  • edge:00175 — intervention_tested_in_trial

Scores are not displayed because no score methodology is qualified for this profile.

Presentation contract

Snapshot mode
DIRECT_GOVERNED_SUMMARY
Opens in a new tab